-
R.
Branch,
C.
Herbert,
A.
Read
(1973)
Determinants of serum antipyrine half-lives in patients with liver disease
Gut, 14
-
R.
Groszmann,
B.
Kotelanski,
J.
Cohn,
I.
Khatri
(1972)
Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease.
The American journal of medicine, 53 6
-
E.
Nelson
(1964)
RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTION
The American Journal of the Medical Sciences, 248
-
J.
Laidlaw,
Read
Ae,
S.
Sherlock
(1961)
Morphine tolerance in hepatic cirrhosis.
Gastroenterology, 40
-
K.
O'malley,
J.
Crooks,
E.
Duke,
I.
Stevenson
(1971)
Effect of Age and Sex on Human Drug Metabolism
British Medical Journal, 3
-
Birgitta
Kolmodin,
D.
Azarnoff,
F.
Sjöqvist
(1969)
Effect of environmental factors on drug metabolism: Decreased plasma half‐life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides
Clinical Pharmacology & Therapeutics, 10
-
A.
Levi,
S.
Sherlock,
D.
Walker
(1968)
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
Lancet, 1 7555
-
Edwin
McLuen,
J.
Fouts
(1961)
THE EFFECT OF OBSTRUCTIVE JAUNDICE ON DRUG METABOLISM IN RABBITS
Journal of Pharmacology and Experimental Therapeutics, 131
-
Elliot
Veseli,
John
Page
(1969)
Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
The Journal of clinical investigation, 48 12
-
U.
Klotz,
T.
McHorse,
G.
Wilkinson,
S.
Schenker
(1974)
The effect of cirrhosis on the disposition and elimination of meperidine in man
Clinical Pharmacology & Therapeutics, 16
-
T.
Hoffman,
R.
Cestero,
W.
Bullock
(1970)
Pharmacodynamics of carbenicillin in hepatic and renal failure.
Annals of internal medicine, 73 2
-
P.
Andreasen,
L.
Ranek,
B.
Statland,
N.
Tygstrup
(1974)
Clearance of Antipyrine‐Dependence of Quantitative Liver Function
European Journal of Clinical Investigation, 4
-
S.
Bradley,
F.
Ingelfinger,
G.
Bradley
(1952)
Hepatic Circulation in Cirrhosis of the Liver
Circulation, 5
-
P.
Joubert,
L.
Rivera-calimlim,
L.
Lasagna
(1975)
The normal volunteer in clinical investigation: How rigid should selection criteria be?
Clinical Pharmacology & Therapeutics, 17
-
W.
Thompson,
A.
Johnson,
W.
Maddrey
(1975)
Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial.
Annals of internal medicine, 82 2
-
P.
Lundbergh
(1974)
Hepatic circulation during and after infectious hepatitis.
Scandinavian journal of infectious diseases, 6 4
-
J.
Forrest,
P.
Roscoe,
L.
Prescott,
I.
Stevenson
(1974)
Abnormal Drug Metabolism after Barbiturate and Paracetamol Overdose
British Medical Journal, 4
-
A.
Read,
J.
Laidlaw,
C.
Mccarthy
(1969)
Effects of Chlorpromazine in Patients with Hepatic Disease
British Medical Journal, 3
-
J.
Sessions,
H.
Minkel,
J.
Bullard,
F.
Ingelfinger
(1954)
The effect of barbiturates in patients with liver disease.
The Journal of clinical investigation, 33 8
-
E.
Richter,
W.
Zilly,
D.
Brachtel,
S.
Becker
(1972)
[Barbiturate tolerance in patients with acute hepatitis].
Deutsche medizinische Wochenschrift, 97 7
-
G.
Acocella,
L.
Bonollo,
M.
Garimoldi,
M.
Mainardi,
Tenconi
Lt,
Nicolis
Fb
(1972)
Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease
Gut, 13
-
U.
Klotz,
G.
Avant,
A.
Hoyumpa,
S.
Schenker,
G.
Wilkinson
(1975)
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
The Journal of clinical investigation, 55 2
-
G.
Wilkinson
(1975)
Pharmacokinetics of drug disposition: hemodynamic considerations.
Annual review of pharmacology, 15
-
J.
Faigle
(2009)
Blood levels of a schistosomicide in relation to liver function and side effects.
Acta pharmacologica et toxicologica, 29 Suppl 3
-
J.
Alvin,
T.
McHorse,
A.
Hoyumpa,
M.
Bush,
S.
Schenker
(1975)
The effect of liver disease in man on the disposition of phenobarbital.
The Journal of pharmacology and experimental therapeutics, 192 1
-
A.
Proudfoot,
N.
Wright
(1970)
Acute Paracetamol Poisoning
British Medical Journal, 3
-
T.
McHorse,
G.
Wilkinson,
R.
Johnson,
S.
Schenker
(1975)
Effect of acute viral hepatitis in man on the disposition and elimination of meperidine.
Gastroenterology, 68 4 Pt 1
-
C.
Lieber
(1973)
Liver adaptation and injury in alcoholism.
The New England journal of medicine, 288 7
-
R.
Stenson,
R.
Constantino,
D.
Harrison
(1971)
Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man
Circulation, 43
-
E.
Hvidberg,
P.
Andreasen,
L.
Ranek
(1974)
Plasma half‐life of phenylbutazone in patients with impaired liver function
Clinical Pharmacology & Therapeutics, 15
-
R.
Preisig,
J.
Rankin,
J.
Sweeting,
S.
Bradley
(1966)
Hepatic Hemodynamics During Viral Hepatitis in Man
Circulation, 34
-
K.
Adjepon-Yamoah,
J.
Nimmo,
L.
Prescott
(1974)
Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
British Medical Journal, 4
-
G.
Hepner,
E.
Vesell
(1974)
Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.
The New England journal of medicine, 291 26
-
R.
Branch,
J.
James,
A.
Read
(1974)
Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.
Gut, 15 10
-
J.
Caesar,
S.
Shaldon,
L.
Chiandussi,
L.
Guevara,
S.
Sherlock
(1961)
The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.
Clinical science, 21
-
J.
Maxwell,
M.
Carrella,
J.
Parkes,
R.
Williams,
G.
Mould,
S.
Curry
(1972)
Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.
Clinical science, 43 2
-
P.
Lundbergh,
T.
Strandell
(2009)
Changes in hepatic circulation at rest, during and after exercise in young males with infectious hepatitis compared with controls.
Acta medica Scandinavica, 196 4
-
M.
Gold,
D.
Ziegler
(1973)
Dimethylaniline N-oxidase and aminopyrine N-demethylase activities of human liver tissue.
Xenobiotica; the fate of foreign compounds in biological systems, 3 3
-
L.
Powell,
E.
Axelsen
(1972)
Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding
Gut, 13
-
P.
Andreasen,
E.
Vesell
(1974)
Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration
Clinical Pharmacology & Therapeutics, 16
-
P.
Thomson,
K.
Melmon,
J.
Richardson,
K.
Cohn,
W.
Steinbrunn,
R.
Cudihee,
M.
Rowland
(1973)
Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.
Annals of internal medicine, 78 4
-
G.
Wilkinson,
D.
Shand
(1975)
A physiological approach to hepatic drug clearance
Clinical Pharmacology & Therapeutics, 18
-
M.
Weiner,
T.
Chenkin,
J.
Burns
(1954)
OBSERVATIONS ON THE METABOLIC TRANSFORMATION AND EFFECTS OF PHENYLBUTAZONE IN SUBJECTS WITH HEPATIC DISEASE
The American Journal of the Medical Sciences, 228
-
T.
Blaschke,
P.
Meffin,
K.
Melmon,
M.
Rowland
(1975)
Influence of acute viral hepatitis on phenytoin kinetics and protein binding
Clinical Pharmacology & Therapeutics, 17
-
L.
Prescott,
P.
Roscoe,
N.
Wright,
S.
Brown
(1971)
Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage.
Lancet, 1 7698
-
S.
Curry
(1972)
Relation between binding to plasma protein, apparent volume of distribution, and rate constants of disposition and elimination for chlorpromazine in three species
Journal of Pharmacy and Pharmacology, 24
-
G.
Mawer,
N.
Miller,
L.
Turnberg
(1972)
Metabolism of amylobarbitone in patients with chronic liver disease
British Journal of Pharmacology, 44
-
M.
Reidenberg
(1971)
Renal Function and Drug Action
-
J.
Gillette
(1971)
FACTORS AFFECTING DRUG METABOLISM
InPharma, 127
-
Hideo
Veda,
T.
Sakurai,
Meisei
Ota,
A.
Nakajima,
K.
Kamii,
H.
Maezawa
(1963)
Disappearance Rate of Tolbutamide in Normal Subjects and in Diabetes Mellitus, Liver Cirrhosis, and Renal Disease
Diabetes, 12
-
C.
Kunin,
A.
Glazko,
M.
Finland
(1959)
Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.
The Journal of clinical investigation, 38